In a report released on January 15, Nik Modi from RBC Capital maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...

Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $88.56 which represents a slight increase of $0.70 or 0.80% from the prior close of $87.86. The stock opened at $87.6 and touched ...

Stifel highlighted that Colgate's Hill's pet nutrition brand continues to be a strong growth driver for the company. In the fourth quarter of 2024, Hill's achieved a remarkable 25% growth, with the ...

CL's solid pricing strategies and premium innovation drive growth, but macroeconomic challenges and currency headwinds ...

Colgate-Palmolive's US$88.56 share price signals that it might be 42% undervalued Analyst price target for CL is US$102 which is 34% below our fair value estimate ...

Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

Pallas Capital Advisors LLC lowered its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6.6% in the 4th quarter, ...

Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $87.67 which represents a slight increase of $0.57 or 0.65% from the prior close of $87.1. The stock opened at $87.21 and touched ...

Six class action complaints accuse major dental product makers of deceptively marketing products containing fluoride to young ...

There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...

Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ...